Charles River Laboratories stock fell early Wednesday, though the medical research firm beat third-quarter forecasts.
Cooke & Bieler, an investment management firm, released its second-quarter investor letter for “Mid Cap Value Equity Strategy.” The letter can be downloaded here. U.S. equities rallied significantly in Q2, driven by shifting geopolitical risks and strong investor appetite for high-beta stocks, particularly in the tech sector, contributing to the S&P 500® and Nasdaq’s best […]
Detailed price information for Natera Inc (NTRA-Q) from The Globe and Mail including charting and trades.
Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.
Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.
Riverwater Partners, an investment management company, released its ‘Sustainable Value Strategy’ Q2 2026 investor letter. The letter can be downloaded here. Small-cap stocks achieved their best first-half performance since 1991, with the Russell 2500 Value Index rising 17%, driven by the technology sector. The Sustainable Value Strategy underperformed its benchmark in the second quarter. The shortfall […]
This is the newest page. Registered accounts read further back.